BIO-TECHNE CORP. DL-,01/ US09073M1045 /
| 2024-11-07 8:08:18 AM | Chg. -3.00 | Volume | Bid8:58:42 PM | Ask8:58:42 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 70.00EUR | -4.11% | 0 Turnover: 0.00 |
70.50Bid Size: 150 | 71.00Ask Size: 140 | 11.31 bill.EUR | - | - |
Assets
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 135.1240 | 145.3480 | 154.0390 | 176.8290 | 207.9070 | ||||||
| Intangible Assets | 452.0420 | 446.3320 | 579.4290 | 516.5450 | 615.9680 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 1,210.1940 | 1,194.8360 | 1,471.8030 | 1,506.6690 | 1,752.3510 | ||||||
| Inventories | 60.1510 | 85.6480 | 91.0500 | 103.1520 | 116.7480 | ||||||
| Accounts Receivable | 116.8300 | 120.2960 | 137.4660 | 122.5340 | 145.3850 | ||||||
| Cash and Cash Equivalents | 91.6120 | 121.9900 | 100.8860 | 146.6250 | 199.0910 | ||||||
| Current Assets | 348.0250 | 398.3660 | 412.6070 | 520.9200 | 510.6060 | ||||||
| Total Assets | 1,558.2190 | 1,593.2020 | 1,884.4100 | 2,027.5890 | 2,262.9570 | ||||||
Liabilities
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 16.8560 | 18.4520 | 16.2100 | 23.0900 | 29.3840 | ||||||
| Long-term debt | 343.7710 | 339 | 492.6600 | 344.2430 | 328.8270 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 120.6000 | 86.3000 | 89.8000 | 101.1000 | 93.1000 | ||||||
| Liabilities | 608.5920 | 514.1410 | 718.8210 | 646.3970 | 691.7230 | ||||||
| Share Capital | 1.4960 | 1.5040 | 1.5160 | 1.5400 | 1.5600 | ||||||
| Total Equity | 949.6270 | 1,079.0610 | 1,165.5890 | 1,381.1920 | 1,571.2340 | ||||||
| Minority Interests | - | - | - | - | 8.2630 | ||||||
| Total liabilities equity | 1,558.2190 | 1,593.2020 | 1,884.4100 | 2,027.5890 | 2,262.9570 | ||||||
Income Statement
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 563.0030 | 642.9930 | 714.0060 | 738.6910 | 931.0320 | ||||||
| Depreciation (total) | 60.0360 | 64.4630 | 78.1710 | 82.7370 | 87.7470 | ||||||
| Operating Result | 120.5840 | 136.1780 | 146.7190 | 157.4190 | 237.2960 | ||||||
| Interest Income | -7.0570 | -9.7790 | -21.1360 | -18.5920 | -13.4790 | ||||||
| Income Before Taxes | 111.9610 | 125.9520 | 112.0150 | 276.4770 | 148.1750 | ||||||
| Income Taxes | 35.8750 | -.1980 | 15.9420 | 47.1810 | 8.5900 | ||||||
| Minority Interests Profit | - | - | - | - | -.8250 | ||||||
| Net Income | 76.0860 | 126.1500 | 96.0720 | 229.2960 | 140.4100 | ||||||
Per Share
Cash Flow
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 143.4480 | 170.3670 | 181.6190 | 205.2170 | 352.1640 | ||||||
| Cash Flow from Investing Activities | -305.9540 | -38.7120 | -336.7990 | 27.0950 | -243.5160 | ||||||
| Cash Flow from Financing | 189.3860 | -99.1880 | 134.3840 | -183.8020 | -62.5510 | ||||||
| Decrease / Increase in Cash | 27.3750 | 30.3780 | -21.1040 | 45.7390 | 52.4660 | ||||||
| Employees | 1,800 | 2,000 | 2,250 | 2,300 | 2,000 | ||||||
